A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/20 (2006.01) A01N 1/02 (2006.01) C12N 5/06 (2006.01) C12N 5/08 (2006.01)
Patent
CA 2245533
Methods of treating animals to prevent or treat the adverse effects of type I or IgE mediated hypersensitivity in the animal consist of administering to the animal a safe and effective amount of a conjugated linoleic acid (CLA) or a substance which is converted in the animal into CLA. Methods of increasing the white blood cell count in a mammal and preserving white blood cells with CLA also are disclosed.
Méthode de traitement des animaux à des fins de prévention ou de traitement des effets néfastes de l'hypersensibilité indirecte de types I ou à médiation IgE chez l'animal, qui consiste à administrer à l'animal une dose sûre et efficace d'un mélange acide linoléique (CLA) conjugué ou d'une substance se transformant en CLA dans le corps de l'animal. Sont également proposées des méthodes d'accroissemen t du chiffre des leucocytes chez les mammifères et de préservation des leucocytes au moyen de CLA.
Cook Ellen B.
Cook Mark E.
Graziano Frank M.
Pariza Michael W.
Stahl James L.
Borden Ladner Gervais Llp
Wisconsin Alumni Research Foundation
LandOfFree
Conjugated linoleic acids for attenuating the allergic response does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Conjugated linoleic acids for attenuating the allergic response, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Conjugated linoleic acids for attenuating the allergic response will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1424014